WebKypha Follow Location: USA Founded in 2009 Private Company "Kypha’s lead product, the CompAct™ Test, uses advanced detection technology and a robust point-of-care format to allow early, accurate detection and real-time monitoring of autoimmune and severe inflammatory disorders. WebDec 20, 2024 · ST LOUIS, /PRNewswire/ -- Kypha, a medical diagnostics company with an innovative testing platform for precision monitoring of immune system activity to improve patient care and advance immune-targeted drug development, has secured $4 million in Series A funding led by Arsenal Capital Management.
Kypha Acquires Biosensia - Expands First-in-Class Immune Status ...
WebMar 3, 2024 · *Planned media availability Monday, March 6 at 10:00 AM* COLUMBIA, S.C. – Scout Motors Inc. (“Scout”) is establishing its first manufacturing plant in Blythewood, … WebKypha seeks to discover, develop and commercialize innovative in-vitro diagnostic biomarker tests within the inflammation and autoimmune space. Its plan is for these tests to become standard of care, having application across a wide range of indications that includ e: lupus, stroke, traumatic brain injury, preeclampsia, infection, kidney ... schweik s years of indiscretion
Kypha: Privacy Policy
WebJul 30, 2024 · Kypha’s Comp act testing platform, analytically validated and GMP-manufactured, includes a small portable instrument with multiple single-use rapid assay cassettes designed to quantitatively measure complement activation biomarkers, from a small volume of blood in either laboratory or point-of-care settings. Biosensia’s RapiPlex … WebNov 7, 2024 · Kypha is a St. Louis-based bioscience company developing diagnostic technologies to improve the way autoimmune, inflammatory and immunologic disorders are monitored and treated. The company is currently advancing its lead product, the Comp Act TM Test, toward regulatory clearance and market launch. Comp Act is a rapid, point-of … WebWhat does KYPHA mean? Kypha Kypha is an early-stage life sciences company developing leading-edge technology and clinically useful products to improve the way autoimmune and inflammatory disorders are monitored and treated. #pragma omp sections